The Role of the SOX9/lncRNA ANXA2P2/miR-361-3p/SOX9 Regulatory Loop in Cervical Cancer Cell Growth and Resistance to Cisplatin

Cervical cancer is a highly prevalent female malignancy. Presently, cisplatin (DDP) is a first-line agent for cervical cancer chemotherapy. However, its curative effect is limited because of chemo-resistance. It has been previously reported that SOX9 targeted and activated oncogenic genes, enhancing...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Shasha, Feng, Yeqian, Zou, Wen, Wang, Jingjing, Li, Guiyuan, Xiong, Wei, Xie, Yangchun, Ma, Jin-an, Liu, Xianling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8784813/
https://www.ncbi.nlm.nih.gov/pubmed/35083143
http://dx.doi.org/10.3389/fonc.2021.784525

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8784813/
https://www.ncbi.nlm.nih.gov/pubmed/35083143
http://dx.doi.org/10.3389/fonc.2021.784525

Ejemplares similares